Stay updated with the latest adverse-event news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on adverse-event topics.
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. Also Read | Indian Railways Carries 1,670 MT Freight, Runs 25,000 Trains Daily in Financial Year 20 ...Read More >
New Delhi [India], April 4 (ANI): The Indian Pharmacopoeia Commission ( IPC), which acts as the National Coordination Centre for the Pharmacovigilance Programme of India (PvPI) and provides evidence-based research to CDSCO, will be monitoring the safety of weight loss drugs. The Indian Pharmacopoeia Commission will be compiling a report of adverse events which are associated with the GLP-1 drugs. According to the Official sources, the IPC has started the regular monitoring of adverse events of ...Read More >
BETHESDA, Md. - Gain Therapeutics, Inc. (NASDAQ:GANX), a $69 million market cap biotech company currently trading at $1.92 per share, announced Monday that its lead drug candidate GT-02287 showed encouraging early results in a Phase 1b clinical study for Parkinson's disease patients. According to InvestingPro data, the company maintains a strong balance sheet with more cash than debt, though it's currently experiencing rapid cash burn typical of early-stage biotechs. The company presented inter ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world's first regulatory approval from India's Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. Also Read | 'Coolie' X Review: Rajinikanth's 'One-Man Show' With Nagarjuna's Stylish Act and Anirudh Rav ...Read More >
Raichur (Karnataka) [India], August 14: In a landmark moment for global hepatology and Indian pharmaceutical innovation, Shilpa Medicare Limited (BSE: 530661) (NSE: SHILPAMED) has secured the world first regulatory approval from India Central Drugs Standard Control Organization (CDSCO) for Nor Ursodeoxycholic Acid (NorUDCA) Tablets 500 mg, the first-ever approved therapy targeting NAFLD. * Shilpa Medicare emerges as the global pioneer to receive approval for NorUDCA, offering new hope to over a ...Read More >
New Delhi, July 14 (SocialNews.XYZ) Dietary approaches like intermittent energy restriction, time-restricted eating, and continuous energy restriction can all improve blood sugar levels and body weight in people with obesity and type 2 diabetes, according to a study. Although researchers identified improved HbA1c levels, and adverse events were similar across the three groups, the IER group showed greater advantages in reducing fasting blood glucose, improving insulin sensitivity, lowering trig ...Read More >
Bengaluru, Jul 5 (PTI) There is no association between premature cardiovascular disease in a patient and a prior history of Covid-19 infection or covid vaccination, an expert committee tasked with investigating the recent cases of heart attack deaths in Karnataka concluded. On the contrary, a report submitted by the panel said that Covid-19 vaccination has been shown to be protective against cardiac events in the long term. The state government constituted an expert committee headed by Dr Ravi ...Read More >
Bengaluru, July 4 (SocialNews.XYZ) Karnataka Chief Minister Siddaramaiah, responding to objections raised by Biocon chief Kiran Mazumdar Shaw over his statement on Covid vaccines causing heart attacks in the state, on Friday, remarked that seeking clarity does not amount to spreading misinformation. Taking to social media site X, Siddaramaiah, defending his statement on linking sudden heart attack deaths in Hassan to a "hasty" Covid vaccine rollout, said: "As Chief Minister, I have a duty to re ...Read More >
Kolkata: The CBI on Wednesday filed a supplementary charge sheet in the 2021 murder case of BJP worker Abhijit Sarkar, who was killed during post-election violence in Kankurgachhi. The charge sheet names Beleghata MLA Paresh Pal, Kolkata Municipal Corporation councillors Swapan Samaddar and Papiya Ghosh, along with 15 others.In the FIR, Sarkar's mother Madhabi said that on May 2, 2021, eight persons barged into their house at Narkeldanga around 3 pm and started enquiring about her son. The miscr ...Read More >
Bengaluru: The Central Drugs Standards Control Organisation (CDCSO) has set up a team to inspect the ethics committee of HCG Hospital, Bengaluru, amid concerns over conduct of clinical trials at the private facility. The inspection will take place Thursday and Friday.The decision follows a letter from K Srinivas, commissioner of food safety and drug administration, to CDCSO, pointing to potential violations in trial conduct that could affect patient safety, regulatory compliance and institutiona ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.